Series B funding round for Prime Medicine raising $200M in July 2021
Series B funding round for Prime Medicine raising $200M in July 2021
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Government Office | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Angel | Daniel Lynch | |
| Angel | Munish Varma | |
| Angel | Julian Zegelman |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$359M
Top Valuation
-
Prime Medicine raised $200M in a Series B round.
The round was announced on 07/01/21.
The round was led by ARCH Venture Partners.